Sivik Global Healthcare LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission disclosing its equity holdings as of September 30, 2026. The filing reveals that the firm manages a portfolio of 35 individual stocks, with the top holding being Abbott Laboratories.
The portfolio is concentrated in the healthcare sector, with a notable allocation to exchange-traded funds. The largest position is Abbott Laboratories, for which the firm holds 55,000 shares. The second-largest holding is Avantor Inc., with 175,000 shares. The firm also holds a significant position in the SPDR S&P Biotech ETF, with 180,000 shares.
Other notable holdings in the portfolio include Cardinal Health, Inc. (25,000 shares); Centene Corp. (80,000 shares); Edwards Lifesciences Corp. (45,000 shares); and Medtronic PLC (45,000 shares). The filing lists William Bruce as the Chief Compliance Officer responsible for the report.
